Predicting swallowing disorders in head and neck cancer patients using ultrasound
Evaluation of the Prognostic Value of Aerodigestive Tract Ultrasound in the Occurrence of Radiotherapy-related Swallowing Disorders in Head and Neck Cancer Patients
This study is testing whether ultrasound can help find out which head and neck cancer patients might have trouble swallowing during their radiotherapy treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 112 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hopital Forcilles Academic / other |
| Locations | 1 site (Férolles-Attilly) |
| Trial ID | NCT06387004 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop a predictive model using ultrasound imaging to assess the risk of swallowing disorders in patients undergoing radiotherapy for head and neck cancers. The study addresses the limitations of traditional assessment methods, which can be invasive and resource-intensive. By utilizing non-invasive ultrasound, researchers hope to provide a more precise evaluation of swallowing-related structures, facilitating targeted rehabilitation and early intervention strategies. The ultimate goal is to improve patient outcomes by identifying those at risk for swallowing disorders early in their treatment.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who are undergoing radiotherapy for head and neck cancer at Hôpital Forcilles.
Not a fit: Patients with neurological disorders or pre-existing swallowing disorders prior to radiotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved early interventions for swallowing disorders, enhancing patients' nutritional status and quality of life.
How similar studies have performed: While ultrasound has been explored in various contexts, this specific predictive model for swallowing disorders in head and neck cancer patients is a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients admitted to Hôpital Forcilles for head and neck cancer radiotherapy; * Ultrasound operator available ; * Patient at least 18 years old at the time of inclusion; * Membership of a social security scheme or beneficiary of such a scheme ; * Oral, free, informed and express patient consent. Exclusion Criteria: * Patients with neurological disorders; * Patients with DR before the start of radiotherapy; * Patient's refusal to participate in the study ; * Person subject to a safeguard of justice measure ; * Patient under guardianship; * Patient with limited care.
Where this trial is running
Férolles-Attilly
- Hôpital Forcilles — Férolles-Attilly, France (Recruiting)
Study contacts
- Principal investigator: DIAZ LOPEZ Carlos, PhD st — Hopital Forcilles
- Study coordinator: LE NEINDRE Aymeric, PhD
- Email: aleneindre@cognacq-jay.fr
- Phone: +33160646093
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.